I agree that this site is using cookies. You can find further informations here.
X
V. O. Sarzhevskiy
11  results:
Search for persons X
?
1

Combined immunochemotherapy in patients with refractory/rel..:

A. A. Mamedova ; N. E. Mochkin ; V. O. Sarzhevskiy...
https://oncohematology.abvpress.ru/ongm/article/view/557.  , 2022
Link: https://doi.org/10.17650..
 
?
2

Effectiveness and safety of empegfilgrastim (Extimia®, BIOC..:

Nesterova, Ekaterina S. ; Saydullaeva, Aleksandra F. ; Sherstnev, Dmitry G....
Journal of Modern Oncology.  25 (2024)  4 - p. 422-431 , 2024
Link: https://doi.org/10.26442..
 
?
3

Effectiveness and safety of empegfilgrastim (Extimia®, BIOC..:

Nesterova, Ekaterina S. ; Saydullaeva, Aleksandra F. ; Sherstnev, Dmitry G....
Journal of Modern Oncology.  24 (2022)  1 - p. 80-88 , 2022
Link: https://doi.org/10.26442..
 
?
4

The role of positron emission tomography in different types..:

Sarzhevskiy, Vladislav O. ; Mukhortova, Olga V.
Journal of Modern Oncology.  23 (2021)  1 - p. 192-200 , 2021
Link: https://doi.org/10.26442..
 
?
5

The phenomenon of pseudoprogression in cancer immunotherapy..:

Sarzhevskiy, Vladislav O. ; Melnichenko, Vladimir Ia. ; Panshina, Irina V....
Journal of Modern Oncology.  23 (2021)  3 - p. 496-500 , 2021
Link: https://doi.org/10.26442..
 
?
6

Effectiveness and safety of empegfilgrastim (Extimia®, BIOC..:

Ekaterina S. Nesterova ; Aleksandra F. Saydullaeva ; Dmitry G. Sherstnev...
https://modernonco.orscience.ru/1815-1434/article/viewFile/106916/81265.  , 2022
Link: https://doi.org/10.26442..
 
?
7

The phenomenon of pseudoprogression in cancer immunotherapy..:

Vladislav O. Sarzhevskiy ; Vladimir Ia. Melnichenko ; Irina V. Panshina...
https://modernonco.orscience.ru/1815-1434/article/viewFile/88627/66807.  , 2021
Link: https://doi.org/10.26442..
 
?
8

The role of positron emission tomography in different types..:

Vladislav O. Sarzhevskiy ; Olga V. Mukhortova
https://modernonco.orscience.ru/1815-1434/article/viewFile/70512/51427.  , 2021
Link: https://doi.org/10.26442..
 
?
9

P1091: FEASIBILITY OF ASCT AFTER ANTI-PD-1 THERAPY FOR R/R ..:

Mochkin, N. ; Sarzhevskiy, V. ; Protopopova, Y....
HemaSphere.  6 (2022)  - p. 981-982 , 2022
Link: https://doi.org/10.1097/..
 
?
10

P1367: COMPARISON CONDITIONING REGIMENS (BEEAC,LEAM,CLV) BE..:

Samoylova, A. ; Sarzhevskiy, V. ; Melnichenko, V....
HemaSphere.  6 (2022)  - p. 1251-1252 , 2022
Link: https://doi.org/10.1097/..
 
?
11

High-dose chemotherapy following autologous hematopoietic s..:

Mochkin, Nikita E. ; Sarzhevskiy, Vladislav O. ; Dubinina, Julia N....
Journal of Modern Oncology.  22 (2020)  2 - p. 126-132 , 2020
Link: https://doi.org/10.26442..
 
1-11